ADVERTISEMENT
News
Parkinson Drug Recalled
03/20/2020
The recall affects carbidopa and levodopa tablets, 25 mg/250 mg, 100-count bottles (NDC 51862-858-01), from lot FG11514 (Exp. 5/21). The bottles were distributed throughout the United States.
Mayne Pharma voluntarily initiated the recall March 2, 2020. At press time, the FDA had not yet issued a recall classification.
Carbidopa and levodopa tablets are available with a prescription to treat symptoms of Parkinson disease.
—Jolynn Tumolo